Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2026

A summary of the stock option activity under the Company’s equity incentive plans is presented below:


	Number of Shares	Weighted Average Exercise Price		Weighted Average Remaining Term	Aggregate Intrinsic Value
Balance as of December 31, 2025	6,000	$	2.85	7.98	$	—
Granted	—	—		—	—
Exercised	—	—		—	—
Forfeited	(42)	2.93		—	—
Expired	(224)	3.13		—	—
Balance as of March 31, 2026	5,734	$	2.84	7.96	$	—
Expected to vest at March 31, 2026	5,734	$	2.84	7.96	$	—
Exercisable at March 31, 2026	3,408	$	3.27	7.85	$	—

A summary of restricted stock unit (“RSU”) activity is presented below:


	Shares	Weighted Average Grant- Date Fair Value
Outstanding as of December 31, 2025	3,170	$	1.84
Granted	615	0.81
Vested	(277)	1.18
Forfeited	(40)	2.00
Outstanding as of March 31, 2026	3,468	$	1.71

The following table summarizes stock-based compensation expense included in the condensed consolidated statements of operations:


	Three Months Ended March 31,
	2026		2025
Cost of revenue, excluding depreciation and amortization	$	352	$	302
Sales and marketing	113		148
General and administrative	921		802
Research and development	166		125
Total	$	1,552	$	1,377